Global Blood Therapeutics (GBT) Priced

Early-stage biotech developing a small molecule therapy for sickle cell disease.

Health Care - Biotechnology

IPO Performance
Latest Trade $28.50 0.00 (0.0%)
First Day Return 115.6%
Return from IPO 42.5%
 
Global Blood Therapeutics IPO News more
  • .
IPO Data
IPO File Date 07/08/2015
Offer Price $20.00
Price Range $16.00 - $18.00
Offer Shares (mm) 6.0
Deal Size ($mm) 120
 
IPO Data
IPO Date 08/11/2015
Offer Price $20.00
Price Range $16.00 - $18.00
Offer Shares (mm) 6.0
Deal Size ($mm) $120
 
Underwriters
more
Business Overview
Early-stage biotech developing a small molecule therapy for sickle cell disease.
Early-stage biotech developing a small molecule therapy for sickle cell disease.
more
Company Data
Headquarters South San Francisco, CA
Founded 2011
Employees 47
Website www.globalbloodtx.com
 

Performance vs. IPO Index (IPOUSA)